Tempero Bio
PrivateCompany Overview
Tempero Bio is a biotechnology company that develops transformative therapies for the treatment and prevention of substance use disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticaldrug discoveryclinical trialssmall-molecule therapeuticsmetabotropic glutamate receptor 5mGluR5alcohol use disorderaddiction medicinebiotechnegative allosteric modulatorNAMpsychiatric medicineneurological disordersdrug developmentclinical-stage
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tempero Bio Comparables
Compare Tempero Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adial Pharmaceuticals, Inc. | 84% | |
| Baseline Therapeutics | 82% | |
| Clearmind Medicine Inc. | 81% | |
Tempero Bio Funding Rounds
Historical fundraising activity
Tempero Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tempero Bio's valuation, stock price, and market status.
See something wrong or outdated?